Saturday, 5 September 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

CABKA EUR 13W Stock Bearish Momentum With A 12% Drop So Far Today

Loading stream...

(VIANEWS) - Shares of CABKA EUR 13W (AEX-Index: DSCW3.AS) dropped by a staggering 12.12% to €0.06 at 14:13 EST on Wednesday, after five consecutive sessions in a row of losses. AEX-Index is falling 0.08% to €757.77, after four successive sessions in a row of gains. This seems, up to now, a somewhat bearish trend trading session today.

CABKA EUR 13W's last close was €0.07, 4.35% under its 52-week high of €0.07.

About CABKA EUR 13W

Yearly Top and Bottom Value

CABKA EUR 13W's stock is valued at €0.06 at 14:13 EST, way under its 52-week low of €0.07.

More news about CABKA EUR 13W (DSCW3.AS).

Categories

stockMarket

Tags

Stock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockDSCW3.ASCABKA EUR 13W
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com